Rankings
▼
Calendar
ALKS Q1 2016 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$157M
Gross Profit
$129M
82.3% margin
Operating Income
-$77M
-49.0% margin
Net Income
-$77M
-49.4% margin
EPS (Diluted)
$-0.51
Cash Flow
Operating Cash Flow
-$57M
Free Cash Flow
-$69M
Stock-Based Comp.
$24M
Balance Sheet
Total Assets
$1.8B
Total Liabilities
$530M
Stockholders' Equity
$1.3B
Cash & Equivalents
$200M
← FY 2016
All Quarters
Q2 2016 →